• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy.

作者信息

Bras Anne E, Beishuizen Auke, Langerak Anton W, Jongen-Lavrencic Mojca, Te Marvelde Jeroen G, van den Heuvel-Eibrink Marry M, Zwaan C Michel, van Dongen Jacques J M, van der Velden Vincent H J

机构信息

Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Department of Paediatric Oncology/Haematology, Erasmus MC - Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

出版信息

Br J Haematol. 2018 Jan;180(2):292-296. doi: 10.1111/bjh.14310. Epub 2016 Sep 8.

DOI:10.1111/bjh.14310
PMID:27604396
Abstract
摘要

相似文献

1
CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy.CD38在儿童白血病和淋巴瘤中的表达：对抗体靶向治疗的意义。
Br J Haematol. 2018 Jan;180(2):292-296. doi: 10.1111/bjh.14310. Epub 2016 Sep 8.
2
CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapy.基于达雷妥尤单抗的化疗后多发性骨髓瘤患者出现CD38阴性复发
Eur J Haematol. 2017 Aug;99(2):186-189. doi: 10.1111/ejh.12902. Epub 2017 Jun 6.
3
Initial frequency of CD34+/CD38 - cells is not correlated with minimal residual disease level in 73 Chinese children with B-cell precursor acute lymphoblastic leukemia.73例中国B细胞前体急性淋巴细胞白血病患儿的CD34+/CD38 - 细胞初始频率与微小残留病水平无关。
Leuk Lymphoma. 2013 Sep;54(9):2073-5. doi: 10.3109/10428194.2013.765566. Epub 2013 Feb 1.
4
A new feature in Leukemia & Lymphoma: "Emerging drug profile".《白血病与淋巴瘤》的一个新特色：“新兴药物概况”。
Leuk Lymphoma. 2013 Oct;54(10):2131-2. doi: 10.3109/10428194.2013.830374.
5
CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia.CD38作为成人急性髓系白血病和T细胞急性淋巴细胞白血病的治疗靶点。
Haematologica. 2019 Mar;104(3):e100-e103. doi: 10.3324/haematol.2018.192757. Epub 2018 Sep 6.
6
CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon.CD38 靶向免疫化疗治疗难治性多发性骨髓瘤：新的曙光。
Clin Cancer Res. 2015 Jun 15;21(12):2660-2. doi: 10.1158/1078-0432.CCR-14-3190. Epub 2015 Apr 15.
7
CD38 variation as a prognostic factor in chronic lymphocytic leukemia.CD38变异作为慢性淋巴细胞白血病的一个预后因素。
Leuk Lymphoma. 2014 Jan;55(1):191-4. doi: 10.3109/10428194.2013.786070. Epub 2013 May 2.
8
Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.外周血CD38高表达的CD8 + 效应记忆T细胞可预测急性移植物抗宿主病。
Biol Blood Marrow Transplant. 2015 Jul;21(7):1215-22. doi: 10.1016/j.bbmt.2015.04.010. Epub 2015 Apr 13.
9
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.用于治疗多发性骨髓瘤的CD38嵌合抗原受体工程化T细胞的临床前评估。
Haematologica. 2016 May;101(5):616-25. doi: 10.3324/haematol.2015.137620. Epub 2016 Feb 8.
10
Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.儿童急性淋巴细胞白血病微小残留病的关键标志物
J Pediatr Hematol Oncol. 2016 Aug;38(6):418-22. doi: 10.1097/MPH.0000000000000624.

引用本文的文献

1
Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells.用单克隆抗体靶向CD38可破坏儿童伯基特淋巴瘤恶性B细胞中的关键生存途径。
Clin Transl Immunology. 2024 Oct 3;13(10):e70011. doi: 10.1002/cti2.70011. eCollection 2024.
2
Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia.裸抗体和抗体药物偶联物：儿童急性淋巴细胞白血病的靶向治疗。
Haematologica. 2024 Jun 1;109(6):1700-1712. doi: 10.3324/haematol.2023.283815.
3
Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study.
达雷妥尤单抗与维奈克拉联合 CAGE 方案治疗晚期复发/难治性 T 细胞急性淋巴细胞白血病/淋巴母细胞淋巴瘤患者：单臂、开放标签、I 期研究。
Ann Hematol. 2024 Aug;103(8):2993-3004. doi: 10.1007/s00277-024-05775-z. Epub 2024 Apr 25.
4
Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions.造血干细胞移植后复发的急性淋巴细胞白血病：当前挑战与未来方向
Onco Targets Ther. 2023 Jan 14;16:1-16. doi: 10.2147/OTT.S274551. eCollection 2023.
5
Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study.急性巨核细胞白血病的免疫表型分析：一项欧洲流式细胞术研究。
Cancers (Basel). 2022 Mar 21;14(6):1583. doi: 10.3390/cancers14061583.
6
Antigen Loss after Targeted Immunotherapy in Hematological Malignancies.针对血液系统恶性肿瘤的靶向免疫治疗后的抗原丢失。
Clin Lab Med. 2021 Sep;41(3):341-357. doi: 10.1016/j.cll.2021.04.005. Epub 2021 Jul 2.
7
The role of CD38 in HIV infection.CD38 在 HIV 感染中的作用。
AIDS Res Ther. 2021 Apr 5;18(1):11. doi: 10.1186/s12981-021-00330-6.
8
High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia.单细胞流式细胞术数据的高维分析可预测儿童急性淋巴细胞白血病的复发
Cancers (Basel). 2020 Dec 23;13(1):17. doi: 10.3390/cancers13010017.
9
CAR T cells for other pediatric non-B-cell hematologic malignancies.嵌合抗原受体 T 细胞治疗其他儿科非 B 细胞血液系统恶性肿瘤。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):494-500. doi: 10.1182/hematology.2020000134.
10
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy.流式细胞术评估新诊断的 T 细胞急性淋巴细胞白血病中 CD38 的表达水平及其在可测量残留疾病、难治性疾病和复发性疾病中对化疗的表达的影响：对抗 CD38 免疫治疗的意义。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000630.